LYSOSOMAL THERAPEUTICS

lysosomal-therapeutics-logo

Lysosomal Therapeutics is dedicated to innovative small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases. Their strategy leverages the clinically-validated link between lysosome-based genetic disorders and neurodegenerative diseases to establish a unique and effective molecular platform for novel drug discovery. LTI’s lead program targets Gaucher-related neurodegeneration, Parkinson’s disease, and other synucleinopathies.

#SimilarOrganizations #People #Financial #Website #More

LYSOSOMAL THERAPEUTICS

Industry:
Biotechnology Health Care Therapeutics

Founded:
2011-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.lysosomaltx.com

Total Employee:
1+

Status:
Active

Contact:
617-913-0166

Email Addresses:
[email protected]

Total Funding:
24.8 M USD

Technology used in webpage:
Viewport Meta SPF SSL By Default LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema Office 365 Mail GoDaddy DNS


Similar Organizations

adicyte-logo

AdiCyte

AdiCyte offers cryopreservation of adipose tissue and stem cells for patients in cosmetics, regenerative medicine and tissue engineering.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

alessa-therapeutics-logo

Alessa Therapeutics

Alessa Therapeutics develops localized treatments for solid organ disease.

afx-medical-logo

AFX Medical

AFX Medical offers precision medicine for brain diseases.

avrion-therapeutics-logo

Avrion Therapeutics

Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.

beat-biotherapeutics-logo

BEAT BioTherapeutics

BEAT BioTherapeutics develops novel therapies for heart diseases.

betr-health-logo

Betr Health

Betr Health delivers digital therapeutics solutions for weight management, hypertension, diabetes, hyperlipidemia, and digestive problems.

biointaxis-logo

Biointaxis

Spinout from the Igtp for neurodegenerative rare diseases.

brainreader-logo

Brainreader

Brainreader develops software which detects neurodegenerative diseases.

cadent-therapeutics-logo

Cadent Therapeutics

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

cajal-neuroscience-logo

Cajal Neuroscience

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

carbylan-therapeutics-logo

Carbylan Therapeutics

Carbylan Therapeutics was founded in 2004

celestial-therapeutics-logo

Celestial Therapeutics

Celestial Therapeutics specializes in the fields of biotechnology, therapeutics, and life science.

celsius-therapeutics-logo

Celsius Therapeutics

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

convalesce-logo

Convalesce

Stem Cell Based Therapy for Neurodegenerative diseases

convergene-logo

ConverGene

ConverGene is a small molecule discovery company leveraging rational drug design.

decedario-logo

Decedario

Decedario is a therapeutic board game for cognitive stimulation.

elicio-therapeutics-logo

Elicio Therapeutics

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

empyrean-therapeutics-logo

Empyrean Therapeutics

Empyrean Therapeutics develops next generation cell therapies to enable global and affordable cures for diseases.

geometer-logo

Geometer

Geometer is entirely focused on helping with the current Covid-19 crisis.

glypharma-therapeutic-logo

GLyPharma Therapeutic

GLyPharma Therapeutic Inc. develops oncology drugs.

hbo2-therapeutics-logo

HbO2 Therapeutics

HbO2 Therapeutics develops and manufactures oxygen carrying solutions.

iaso-therapeutics-logo

Iaso Therapeutics

Iaso Therapeutics develops vaccines to improve human health and cure diseases.

immunity-pharma-logo

Immunity Pharma

Immunity Pharma specializes in developing therapies for neurodegenerative diseases.

inflammasome-therapeutics-logo

Inflammasome Therapeutics

Inflammasome Therapeutics Inc found to develop therapies for prevalent, degenerative diseases.

institute-for-stem-cell-and-regenerative-medicine-logo

INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE

ISCRM is working to transform therapies for heart failure, neurodegenerative diseases.

kaya-ventures-logo

Kaya Ventures

Kaya Ventures provides building a healthier, happier, and more empowered future.

level-logo

Level

Level is a mental healthcare solution delivered to employees anywhere via the Level app.

intrinsic-medicine-logo

Intrinsic Medicine

New Medicines for Underserved Gut-Brain-Axis Disorders

mitochem-therapeutics-logo

MitoChem Therapeutics

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

modis-therapeutics-logo

Modis Therapeutics

Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.

neuradom-logo

Neuradom

Neuradom specializing in the home support of people with neurodegenerative diseases.

neuroinitiative-logo

NeuroInitiative

Neuroinitiative is dedicated to the advancement of research and understanding two neurodegenerative disorders, Alzheimer’s & Parkinson’s

neuromagen-pharma-logo

Neuromagen Pharma

Neuromagen Pharma develops drugs for neurodegenerative diseases including ALS.

novel-therapeutic-technologies-logo

Novel Therapeutic Technologies

Novel Therapeutic Technology develops practical drug delivery systems.

padlock-therapeutics-logo

Padlock Therapeutics

Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more.

peptineo-logo

Peptineo

Peptineo provides Nano-based therapeutics for existing and emerging diseases.

promakhos-therapeutics-logo

Promakhos Therapeutics

Promakhos Therapeutics provides a therapeutics platform for curing inflammatory disorders.

proneurotech-logo

ProNeurotech

ProNeurotech is a developer of neuroprotective drugs that prevent axon loss after acute injury or chronic degenerative disease.

rarebase-logo

Rarebase

Biomedical R&D for Rare Disease

remd-biotherapeutics-logo

REMD Biotherapeutics

REMD Biotherapeutics provides medications for chronic illnesses such as metabolic diseases.

rodin-therapeutics-logo

Rodin Therapeutics

Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.

rosetta-therapeutics-logo

Rosetta Therapeutics

Rosetta Therapeutics is a developer of new molecular matter as leads for the cure of neurodegenerative diseases.

serenity-bioworks-logo

Serenity Bioworks

Developing therapeutics derived from cellular stress pathways.

sinfonia-biotherapeutics-logo

Sinfonia Biotherapeutics

Sinfonia Biotherapeutics Developing novel, bioreactor-delivered treatments for familial & genetically-defined ​neurodegenerative diseases.

not_available_image

SingletO2 Therapeutics

SingletO2 Therapeutics develops new treatments for periodontal disease using singlet oxygen.

tomegavax-logo

TomegaVax

TomegaVax is developing cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

zenobia-therapeutics-logo

Zenobia Therapeutics

Zenobia Therapeutics is a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery.


Current Advisors List

bernard-davitian_image

Bernard Davitian Board of Directors @ Lysosomal Therapeutics
Board_member

bob-carpenter_image

Bob Carpenter Chairman @ Lysosomal Therapeutics
Board_member

carole-nuechterlein_image

Carole Nuechterlein Board of Directors @ Lysosomal Therapeutics
Board_member

clay-b-thorp_image

Clay B. Thorp Board of Directors @ Lysosomal Therapeutics
Board_member

steve-hall_image

Steve Hall Board of Directors @ Lysosomal Therapeutics
Board_member

bruce-booth_image

Bruce Booth Member of the Board of Directors @ Lysosomal Therapeutics
Board_member

Current Employees Featured

edmund-sybertz_image

Edmund Sybertz
Edmund Sybertz Founder @ Lysosomal Therapeutics
Founder

joseph-mazzulli_image

Joseph Mazzulli
Joseph Mazzulli Scientific Founder @ Lysosomal Therapeutics
Scientific Founder

henri-termeer_image

Henri Termeer
Henri Termeer Founder @ Lysosomal Therapeutics
Founder
2014-01-01

dimitri-krainc_image

Dimitri Krainc
Dimitri Krainc Scientific Founder, Chairman of the Scientific Advisory Board @ Lysosomal Therapeutics
Scientific Founder, Chairman of the Scientific Advisory Board

mark-carthy_image

Mark Carthy
Mark Carthy Investor @ Lysosomal Therapeutics
Investor
2014-05-01

Founder


dimitri-krainc_image

Dimitri Krainc

edmund-sybertz_image

Edmund Sybertz

henri-termeer_image

Henri Termeer

joseph-mazzulli_image

Joseph Mazzulli

kees-been_image

Kees Been

peter-wirth_image

Peter Wirth

Investors List

partners-innovation-fund_image

Partners Innovation Fund

Partners Innovation Fund investment in Series A - Lysosomal Therapeutics

orion-healthcare-equity-partners_image

Orion Healthcare Equity Partners

Orion Healthcare Equity Partners investment in Series A - Lysosomal Therapeutics

henri-termeer_image

Henri Termeer

Henri Termeer investment in Series A - Lysosomal Therapeutics

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series A - Lysosomal Therapeutics

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Series A - Lysosomal Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series A - Lysosomal Therapeutics

lilly-ventures_image

Lilly Ventures

Lilly Ventures investment in Series A - Lysosomal Therapeutics

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series A - Lysosomal Therapeutics

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Seed Round - Lysosomal Therapeutics

orion-healthcare-equity-partners_image

Orion Healthcare Equity Partners

Orion Healthcare Equity Partners investment in Seed Round - Lysosomal Therapeutics

Investments List

Date Company Article Money raised
2016-08-22 Amylyx Pharmaceuticals Lysosomal Therapeutics investment in Series A - Amylyx Pharmaceuticals 5 M USD
2015-09-22 Artax Biopharma Lysosomal Therapeutics investment in Series B - Artax Biopharma 10 M USD
2015-03-05 Aura Biosciences Lysosomal Therapeutics investment in Series B - Aura Biosciences 21 M USD
2011-11-07 NanoString Technologies Lysosomal Therapeutics investment in Series D - NanoString Technologies 20 M USD

Official Site Inspections

http://www.lysosomaltx.com

  • Host name: server119-2.web-hosting.com
  • IP address: 198.54.115.108
  • Location: Los Angeles United States
  • Latitude: 34.0318
  • Longitude: -118.4252
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90064

Loading ...

More informations about "Lysosomal Therapeutics" on Search Engine